DONGSUNG CHEMICAL Co., Ltd. (KRX:102260)

DONGSUNG CHEMICAL Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,219,870	1,066,318	993,004	1,140,124	925,979	864,010
Other Revenue	-	-	-	-	-	0
Revenue	1,219,870	1,066,318	993,004	1,140,124	925,979	864,010
Revenue Growth (YoY)	20.95%	7.38%	-12.90%	23.13%	7.17%	1.67%
Cost of Revenue	997,767	870,539	830,399	995,688	789,984	700,154
Gross Profit	222,103	195,779	162,605	144,435	135,994	163,856
Selling, General & Admin	98,613	92,172	80,133	82,106	81,787	79,600
Research & Development	3,967	3,175	2,535	2,285	1,793	1,625
Amortization of Goodwill & Intangibles	831.02	872.5	1,075	1,154	893.16	889.2
Other Operating Expenses	2,342	2,027	1,516	1,459	1,632	2,258
Operating Expenses	112,560	104,837	88,534	89,239	92,435	98,857
Operating Income	109,543	90,942	74,071	55,196	43,559	64,999
Interest Expense	-3,924	-4,555	-8,603	-5,382	-5,362	-8,298
Interest & Investment Income	2,480	3,336	7,007	4,554	1,804	962.54
Earnings From Equity Investments	748.95	-72.84	-5,073	-4,420	-1,531	8,671
Currency Exchange Gain (Loss)	1,669	7,357	1,450	7,602	6,192	-4,709
Other Non Operating Income (Expenses)	7,495	-2,612	46.02	-6,385	7,809	-611.91
EBT Excluding Unusual Items	118,013	94,394	68,897	51,164	52,472	61,013
Gain (Loss) on Sale of Investments	-4,226	-4,193	-3,348	5,221	2,640	-70.28
Gain (Loss) on Sale of Assets	-271.95	-1,193	-1,734	-357.8	1,146	-1,253
Asset Writedown	-	-	-	-255.26	-2,622	-4,401
Pretax Income	113,515	89,009	63,815	55,773	53,636	55,289
Income Tax Expense	29,931	27,811	9,213	8,940	12,196	11,092
Earnings From Continuing Operations	83,584	61,198	54,602	46,833	41,440	44,197
Earnings From Discontinued Operations	-0	16,783	4,113	-	951.72	-7,016
Net Income to Company	83,584	77,981	58,715	46,833	42,392	37,182
Minority Interest in Earnings	-45,425	-33,030	-25,261	-11,792	-24,479	-30,508
Net Income	38,158	44,951	33,454	35,041	17,913	6,673
Net Income to Common	38,158	44,951	33,454	35,041	17,913	6,673
Net Income Growth	9.77%	34.37%	-4.53%	95.62%	168.43%	18.43%
Shares Outstanding (Basic)	49	49	49	50	49	44
Shares Outstanding (Diluted)	50	50	50	50	49	45
Shares Change (YoY)	-0.01%	-0.09%	-0.92%	1.21%	10.47%	-0.74%
EPS (Basic)	776.38	914.54	680.69	706.74	367.55	150.19
EPS (Diluted)	770.27	907.22	675.07	700.99	362.82	149.13
EPS Growth	9.74%	34.39%	-3.70%	93.21%	143.29%	19.54%
Free Cash Flow	107,105	-715.98	82,648	18,493	-34,007	102,807
Free Cash Flow Per Share	2163.41	-14.46	1667.49	369.70	-688.06	2297.91
Dividend Per Share	50.000	50.000	198.020	198.020	198.020	247.525
Dividend Growth	-74.75%	-74.75%	-	-	-20.00%	25.00%
Gross Margin	18.21%	18.36%	16.38%	12.67%	14.69%	18.96%
Operating Margin	8.98%	8.53%	7.46%	4.84%	4.70%	7.52%
Profit Margin	3.13%	4.22%	3.37%	3.07%	1.93%	0.77%
Free Cash Flow Margin	8.78%	-0.07%	8.32%	1.62%	-3.67%	11.90%
EBITDA	142,119	116,708	100,506	78,649	69,262	92,317
EBITDA Margin	11.65%	10.95%	10.12%	6.90%	7.48%	10.69%
D&A For EBITDA	32,576	25,767	26,435	23,452	25,703	27,318
EBIT	109,543	90,942	74,071	55,196	43,559	64,999
EBIT Margin	8.98%	8.53%	7.46%	4.84%	4.70%	7.52%
Effective Tax Rate	26.37%	31.25%	14.44%	16.03%	22.74%	20.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.